{"id":"NCT02738879","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Randomized Sitagliptin Withdrawal Study (MK-0431-845)","officialTitle":"A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of the Continuation of Sitagliptin Compared With the Withdrawal of Sitagliptin During Initiation and Titration of Insulin Glargine (LANTUS速) in Subjects With Type 2 Diabetes Mellitus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-05-09","primaryCompletion":"2018-01-22","completion":"2018-01-30","firstPosted":"2016-04-14","resultsPosted":"2019-02-25","lastUpdate":"2019-02-25"},"enrollment":746,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Sitagliptin","otherNames":["Januvia速"]},{"type":"DRUG","name":"Placebo to sitagliptin","otherNames":[]},{"type":"DRUG","name":"Metformin","otherNames":[]},{"type":"DRUG","name":"Metformin XR","otherNames":[]},{"type":"DRUG","name":"Insulin glargine","otherNames":["LANTUS速)"]}],"arms":[{"label":"Sitagliptin","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a trial of continuing sitagliptin versus withdrawing sitagliptin in participants with Type 2 diabetes mellitus (T2DM) and inadequate glycemic control who initiate and titrate insulin glargine (LANTUS速) based on a treat-to-target algorithm to achieve fasting glucose levels of 72-100 mg/dL (4-5.6 mmol/L). A primary hypothesis of this trial is that after 30 weeks, continuing sitagliptin results in a greater reduction of hemoglobin A1C (A1C) relative to withdrawing sitagliptin.","primaryOutcome":{"measure":"Change From Baseline in A1C at Week 30","timeFrame":"Baseline and Week 30","effectByArm":[{"arm":"Sitagliptin","deltaMin":-1.88,"sd":-1.98},{"arm":"Placebo","deltaMin":-1.42,"sd":-1.52}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":"< 0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["30393950"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":14,"n":373},"commonTop":["Hypoglycaemia","Nasopharyngitis","Headache"]}}